Procter & Gamble (NYSE: PG) reported Q3 EPS of $1.37, $0.05 better than the analyst estimate of $1.32. Revenue for the quarter came in at $20.1 billion versus the consensus estimate of $19.25 billion.

GUIDNACE:

P&G raised its guidance for fiscal 2023 all-in sales to grow approximately one percent versus the prior fiscal year, from a prior guidance range of down one percent to in-line. The Company also raised its outlook for organic sales growth to approximately six percent versus the prior fiscal year from a prior growth range of four to five percent. Foreign exchange is expected to be a five percentage point headwind to all-in sales growth for the fiscal year.

P&G maintained its outlook for fiscal 2023 diluted net earnings per share growth in the range of in-line to up four percent versus fiscal 2022 EPS of $5.81. The Company added that it expects EPS results towards the lower end of the fiscal year guidance range

For earnings history and earnings-related data on Procter & Gamble (PG) click here.